Drug comparisons
Nateglinide vs Troglitazone
Nateglinide is a rapid insulin secretagogue, troglitazone an insulin sensitizer. Troglitazone removed from market due to liver risks.
No comparison dimensions are available for this page.
Clinical context
Doctors comparing nateglinide, a rapid-acting insulin secretagogue, with troglitazone, a thiazolidinedione, in type 2 diabetes treatment.
Bottom line
Nateglinide remains a valid antidiabetic choice while troglitazone is no longer available due to safety concerns.
All medication comparisons